Qianming Du
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 4
- Immunology top 5%
- Immune cells in cancer 9
- Cancer Research top 10%
- Molecular Biology top 10%
- Inflammasome and immune disorders 7
-
- Nanoparticle-Based Drug Delivery 8
-
- Nanoplatforms for cancer theranostics 4
-
- Drug Transport and Resistance Mechanisms 4
- Cancer Immunotherapy and Biomarkers 4
-
- Estrogen and related hormone effects 4
- Co-authors
- Rong HuXiuting LiuChao LiuYubing ZhuJianing WangYajing WangJianjun ZouWei Zhou
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qianming Du
52 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 106
- Biological Psychiatry 100
- Immunology 458
- Cancer Research 240
- Molecular Biology 982
- Complementary and alternative medicine 115
Countries citing papers authored by Qianming Du
This map shows the geographic impact of Qianming Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianming Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianming Du more than expected).
Fields of papers citing papers by Qianming Du
This network shows the impact of papers produced by Qianming Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianming Du. The network helps show where Qianming Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qianming Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 11 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 31 | |
| 12 | 2023 | 67 | |
| 13 | 2022 | 15 | |
| 14 | 2021 | 18 | |
| 15 | 2020 | 27 | |
| 16 | 2018 | 48 | |
| 17 | 2018 | 51 | |
| 18 | 2017 | 127 | |
| 19 | 2016 | 84 | |
| 20 | 2016 | 19 |
About Qianming Du
Qianming Du is a scholar working on Biological Psychiatry, Biomaterials and Immunology, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Nanoparticle-Based Drug Delivery (8 papers), Inflammasome and immune disorders (7 papers), Nanoplatforms for cancer theranostics (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Estrogen and related hormone effects (4 papers) and Tryptophan and brain disorders (4 papers). The work is most often cited by research in Biological Psychiatry (100 citations), Immunology (458 citations) and Cancer Research (240 citations). Qianming Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Rong Hu, Xiuting Liu, Chao Liu, Yubing Zhu, Jianing Wang, Yajing Wang, Jianjun Zou, Wei Zhou, Yang Ding and Ping Lü. Their work appears in journals such as ACS Nano, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.